Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-MEMANTINE 10MG TABLET Resolved 2017-03-10 2017-04-04 381
APO-MEMANTINE 10MG TABLET Resolved 2017-06-28 2020-06-03 14191
APO-MEMANTINE 10MG TABLET Resolved 2022-07-29 2022-10-14 165723
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-01-28 69915
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-08 2019-06-24 83504
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-07-03 2019-08-03 88336
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2021-05-03 100281
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2023-07-04 100284
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-14 2021-06-14 139413
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-07-23 2021-10-05 142982
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-07 2021-12-06 146795
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-12-09 2022-01-24 150839
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-27 2022-06-03 161442
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-02-23 184100
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-09 2023-04-06 186575
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-14 2024-02-02 189647
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-13 2023-10-15 201719
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-26 212362

Showing 1861 to 1880 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750

Showing 261 to 280 of 366